193 related articles for article (PubMed ID: 26759016)
21. Targeting bladder tumor cells in vivo and in the urine with a peptide identified by phage display.
Lee SM; Lee EJ; Hong HY; Kwon MK; Kwon TH; Choi JY; Park RW; Kwon TG; Yoo ES; Yoon GS; Kim IS; Ruoslahti E; Lee BH
Mol Cancer Res; 2007 Jan; 5(1):11-9. PubMed ID: 17259343
[TBL] [Abstract][Full Text] [Related]
22. Targeting phosphatidylserine on apoptotic cells with phages and peptides selected from a bacteriophage display library.
Shao R; Xiong C; Wen X; Gelovani JG; Li C
Mol Imaging; 2007; 6(6):417-26. PubMed ID: 18053412
[TBL] [Abstract][Full Text] [Related]
23. Lung Cancer-Targeting Peptides with Multi-subtype Indication for Combinational Drug Delivery and Molecular Imaging.
Chi YH; Hsiao JK; Lin MH; Chang C; Lan CH; Wu HC
Theranostics; 2017; 7(6):1612-1632. PubMed ID: 28529640
[TBL] [Abstract][Full Text] [Related]
24. Production and radioimmunoimaging of novel fully human phage display recombinant antibodies and growth inhibition of lung adenocarcinoma cell line overexpressing Prx I.
Luo Y; Pang H; Li S; Cao H; Peng Z; Fan C; Li S
Cancer Biol Ther; 2009 Jul; 8(14):1369-77. PubMed ID: 19556853
[TBL] [Abstract][Full Text] [Related]
25. Phage display peptide probes for imaging early response to bevacizumab treatment.
Cao Q; Liu S; Niu G; Chen K; Yan Y; Liu Z; Chen X
Amino Acids; 2011 Nov; 41(5):1103-12. PubMed ID: 20232090
[TBL] [Abstract][Full Text] [Related]
26. Identification of a cardiac specific protein transduction domain by in vivo biopanning using a M13 phage peptide display library in mice.
Zahid M; Phillips BE; Albers SM; Giannoukakis N; Watkins SC; Robbins PD
PLoS One; 2010 Aug; 5(8):e12252. PubMed ID: 20808875
[TBL] [Abstract][Full Text] [Related]
27. Phage display-derived peptides for osteosarcoma imaging.
Sun X; Niu G; Yan Y; Yang M; Chen K; Ma Y; Chan N; Shen B; Chen X
Clin Cancer Res; 2010 Aug; 16(16):4268-77. PubMed ID: 20570932
[TBL] [Abstract][Full Text] [Related]
28. An immuno-precipitation assay for determining specific interactions between antibodies and phage selected from random peptide expression libraries.
Al-bukhari TA; Tighe P; Todd I
J Immunol Methods; 2002 Jun; 264(1-2):163-71. PubMed ID: 12191519
[TBL] [Abstract][Full Text] [Related]
29. Discovery of a phosphatidylserine-recognizing peptide and its utility in molecular imaging of tumour apoptosis.
Thapa N; Kim S; So IS; Lee BH; Kwon IC; Choi K; Kim IS
J Cell Mol Med; 2008; 12(5A):1649-60. PubMed ID: 18363834
[TBL] [Abstract][Full Text] [Related]
30. Using Dual Fluorescence Reporting Genes to Establish an In Vivo Imaging Model of Orthotopic Lung Adenocarcinoma in Mice.
Lai CW; Chen HL; Yen CC; Wang JL; Yang SH; Chen CM
Mol Imaging Biol; 2016 Dec; 18(6):849-859. PubMed ID: 27197534
[TBL] [Abstract][Full Text] [Related]
31. Peptide-mediated targeting to tumor blood vessels of lung cancer for drug delivery.
Lee TY; Lin CT; Kuo SY; Chang DK; Wu HC
Cancer Res; 2007 Nov; 67(22):10958-65. PubMed ID: 18006841
[TBL] [Abstract][Full Text] [Related]
32. Non-specific translocation of peptide-displaying bacteriophage particles across the gastrointestinal barrier.
Hamzeh-Mivehroud M; Mahmoudpour A; Rezazadeh H; Dastmalchi S
Eur J Pharm Biopharm; 2008 Oct; 70(2):577-81. PubMed ID: 18602466
[TBL] [Abstract][Full Text] [Related]
33. Targeted binding of the M13 bacteriophage to thiamethoxam organic crystals.
Cho W; Fowler JD; Furst EM
Langmuir; 2012 Apr; 28(14):6013-20. PubMed ID: 22404231
[TBL] [Abstract][Full Text] [Related]
34. A Phage Display-Identified Peptide Selectively Binds to Kidney Injury Molecule-1 (KIM-1) and Detects KIM-1-Overexpressing Tumors in vivo.
Haque ME; Khan F; Chi L; Gurung S; Vadevoo SMP; Park RW; Kim DK; Kim SK; Lee B
Cancer Res Treat; 2019 Jul; 51(3):861-875. PubMed ID: 30282451
[TBL] [Abstract][Full Text] [Related]
35. Architectonics of phage-liposome nanowebs as optimized photosensitizer vehicles for photodynamic cancer therapy.
Kalarical Janardhanan S; Narayan S; Abbineni G; Hayhurst A; Mao C
Mol Cancer Ther; 2010 Sep; 9(9):2524-35. PubMed ID: 20807781
[TBL] [Abstract][Full Text] [Related]
36. A strategy for actualization of active targeting nanomedicine practically functioning in a living body.
Lee KJ; Shin SH; Lee JH; Ju EJ; Park YY; Hwang JJ; Suh YA; Hong SM; Jang SJ; Lee JS; Song SY; Jeong SY; Choi EK
Biomaterials; 2017 Oct; 141():136-148. PubMed ID: 28688285
[TBL] [Abstract][Full Text] [Related]
37. Selection and identification of novel peptides specifically targeting human cervical cancer.
Liu X; Peng J; He J; Li Q; Zhou J; Liang X; Tang S
Amino Acids; 2018 May; 50(5):577-592. PubMed ID: 29435721
[TBL] [Abstract][Full Text] [Related]
38. Screening peptides binding specifically to colorectal cancer cells from a phage random peptide library.
Wang JJ; Liu Y; Zheng Y; Liao KX; Lin F; Wu CT; Cai GF; Yao XQ
Asian Pac J Cancer Prev; 2012; 13(1):377-81. PubMed ID: 22502705
[TBL] [Abstract][Full Text] [Related]
39. Spectroscopically well-characterized RGD optical probe as a prerequisite for lifetime-gated tumor imaging.
Mathejczyk JE; Pauli J; Dullin C; Napp J; Tietze LF; Kessler H; Resch-Genger U; Alves F
Mol Imaging; 2011 Dec; 10(6):469-80. PubMed ID: 22201538
[TBL] [Abstract][Full Text] [Related]
40. Identification and binding mechanism of phage displayed peptides with specific affinity to acid-alkali treated titanium.
Sun Y; Tan J; Wu B; Wang J; Qu S; Weng J; Feng B
Colloids Surf B Biointerfaces; 2016 Oct; 146():307-17. PubMed ID: 27371890
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
